7th Omnibus – ban for Dimethyltolylamine and Trimethylbenzoyl diphenylphosphine oxide

At the beginning of March, the EU Commission notified to the World Trade Organisation (WTO) the draft text od the 21st Adaptation to Technical Progress (ATP) to the EU Classification, Labelling and Packaging (CLP) Regulation.

The draft ATP amends Annex VI of the EU CLP Regulation and it includes new Carcinogenic, Mutagenic and Reprotoxic (CMR) classifications relating to the cosmetics ingredients listed below.

  • Dimethyltolylamine, carcinogenic 1B – no current Annex entry in the EU Cosmetics Regulation
  • Diuron (ISO), carcinogen 1B – already banned for use in cosmetics as included in Annex II entry 1058 of the EU Cosmetics Regulation
  • Trimethylbenzoyl diphenylphosphine oxide, reprotoxic 1B – currently found In Annex III entry 311 of the EU Cosmetics Regulation
  • Cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2- (methoxyimino)acetamide, reprotoxic 2 – already banned for use in cosmetics as included in Annex II entry 1580 of the EU Cosmetics Regulation

These ingredients were not defended by industry and will therefore be included in Annex II (prohibited substances) of the Cosmetics regulation 1223/2009 via the seventh CMR Omnibus Regulation.

The making available (off-shelf) deadline for products containing these substances will be 18 months after publication of the 21st ATP to CLP on the EU Official Journal.

It is important to note that this new legislation will not automatically be included within the Great Britain (GB) CLP Regulation.  So currently, the announced bans will apply only in the EU.